Cardiorenal Medicine
Overview
Cardiorenal Medicine is a scientific journal, published by Karger since 2011 in English. The journal's country of origin is Switzerland and its primary focus areas are endocrinology, cardiology & vascular diseases and nephrology.
Details
Details
Abbr.
Cardiorenal Med
Publisher
Karger
Start
2011
End
Continuing
Frequency
Four no. a year
p-ISSN
1664-3828
e-ISSN
1664-5502
Country
Switzerland
Language
English
Specialties
Endocrinology
Cardiology & Vascular Diseases
Nephrology
Cardiology & Vascular Diseases
Nephrology
Metrics
Metrics
h-index / Ranks: 10441
30
SJR / Ranks: 5693
758
CiteScore / Ranks: 5069
5.00
JIF / Ranks: 2461
3.8
Recent Articles
1.
Chen Z, Wang S, Liu L, Yin L, Xu X, Xiong J, et al.
Cardiorenal Med
. 2025 Mar;
:1-20.
PMID: 40037314
Background: Emerging evidence indicates that serum polyamines, including putrescine, spermidine, and spermine, may serve as potential biomarkers for chronic kidney disease (CKD) and its progression. However, the association between serum...
2.
Kazory A, Ronco C
Cardiorenal Med
. 2025 Feb;
:1-12.
PMID: 39978316
This is an overview of some of the impactful studies in the field of cardiorenal medicine that were published in 2024.
3.
Pei Y, Guo L, Zhou G, Cao L, Huang W, Yang F, et al.
Cardiorenal Med
. 2025 Feb;
:1-18.
PMID: 39961282
Introduction: Cardiorenal syndrome (CRS) is a common and critical complication of sepsis, with high morbidity and mortality rates. Studies on biomarkers for the early prediction of septic CRS are sporadic....
4.
Paccagnella C, Andreola S, Gambaro A, Gambaro G, Caletti C
Cardiorenal Med
. 2025 Feb;
:1-38.
PMID: 39956105
Background: Kidney transplantation is the best treatment for patients with chronic renal failure, capable of improving life expectancy and the risk of death from all causes, which, however, remains higher...
5.
Koratala A, Ronco C, Kazory A
Cardiorenal Med
. 2025 Feb;
15(1):184-197.
PMID: 39933496
Background: Accumulating evidence has challenged the traditional model of the liver-kidney connection in hepatorenal syndrome. Cirrhosis can significantly impact cardiac function, leading to cirrhotic cardiomyopathy. Recent understanding reveals how cardiac...
6.
Leon-Roman J, Azancot M, Marouco C, Patricio-Liebana M, Zamora J, Ramos Terrades N, et al.
Cardiorenal Med
. 2025 Jan;
15(1):174-183.
PMID: 39864430
Introduction: Approximately 70% of patients with heart failure (HF) also have kidney disease. Mortality is increased both by cardiorenal syndrome (CRS) and by the exacerbation of other comorbidities. The purpose...
7.
Ye Z, Xie E, Guo Z, Gao Y, Han Z, Dou K, et al.
Cardiorenal Med
. 2025 Jan;
15(1):153-163.
PMID: 39837280
Introduction: The objective of this research was to explore the possible link between markers of liver fibrosis and survival rates in a group of adults who have been diagnosed with...
8.
Kreitzer N, Albert N, Amin A, Beavers C, Becker R, Fonarow G, et al.
Cardiorenal Med
. 2025 Jan;
15(1):133-152.
PMID: 39809248
Background: Hyperkalemia, generally defined as serum potassium levels greater than 5.0 mEq/L, poses significant clinical risks, including cardiac toxicity and muscle weakness. Its prevalence and severity increase in patients with...
9.
Nunez-Marina G, Nunez-Marin G, Santas E
Cardiorenal Med
. 2025 Jan;
15(1):108-121.
PMID: 39778558
Background: Heart failure with preserved ejection fraction (HFpEF) and chronic kidney disease (CKD) have a strong pathophysiological interrelationship, and their combination worsens prognosis. Summary: This article briefly reviews the bidirectional...
10.
Tsai T, Fan P, Lee C, Chen S, Chen J, Chan M, et al.
Cardiorenal Med
. 2025 Jan;
15(1):164-173.
PMID: 39778556
Introduction: Patients on extracorporeal membrane oxygenation (ECMO) often experience worse renal outcomes and higher mortality rates as the severity of kidney injury increases. Nevertheless, the in-hospital mortality risks of patients...